Get the Stockscreener App
7.02
0.00%
0.00
After Hours:
7.02
Kamada Ltd stock is traded at $7.02, with a volume of 79,750.
It is up +0.00% in the last 24 hours and down -3.57% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$7.02
Open:
$6.99
24h Volume:
79,750
Relative Volume:
1.03
Market Cap:
$404.92M
Revenue:
$154.57M
Net Income/Loss:
$15.07M
P/E Ratio:
26.00
EPS:
0.27
Net Cash Flow:
$10.92M
1W Performance:
-0.85%
1M Performance:
-3.57%
6M Performance:
+1.15%
1Y Performance:
+21.24%
1-Day Range:
$6.94
$7.0858
1-Week Range:
$6.631
$7.0858
52-Week Range:
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.02 | 404.92M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World
HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World
Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria
Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com
Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks
Kamada reiterates FY25 revenue guidance $178M-$182M - TipRanks
Kamada (KMDA) Halts Phase 3 Trial of Inhaled AAT for Alpha-1 Ant - GuruFocus
Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026 - TipRanks
Kamada reiterates 2025 FY revenue guidance of $178M-$182M - marketscreener.com
Kamada Reiterates 2025 FY Revenue Guidance Of $178M-$182M - TradingView
Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial By Investing.com - Investing.com Canada
Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial - Investing.com
Kamada (NASDAQ: KMDA) drops inhaled AAT study, reaffirms $178M-$182M 2025 revenue - Stock Titan
Shareholders May Not Be So Generous With Kamada Ltd.'s (TLV:KMDA) CEO Compensation And Here's Why - simplywall.st
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average – Time to Sell? - Defense World
Technical Reactions to KMDA Trends in Macro Strategies - news.stocktradersdaily.com
Kamada updates proxy statement ahead of annual shareholder meeting By Investing.com - Investing.com Australia
Kamada updates proxy statement ahead of annual shareholder meeting - Investing.com
Is Kamada Ltd. stock positioned well for digital economyJuly 2025 Patterns & Weekly Consistent Profit Watchlists - moha.gov.vn
Is Kamada Ltd. stock affected by interest rate hikesWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - BỘ NỘI VỤ
Will Kamada Ltd. stock see insider buyingQuarterly Portfolio Summary & Precise Trade Entry Recommendations - moha.gov.vn
Kamada Ltd. (NASDAQ:KMDA) Q3 2025 Earnings Call Transcript - MSN
Kamada (NASDAQ:KMDA) Stock Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat
Is Kamada's Dual Focus On Plasma Capacity And Clinical Trials Unlocking New Opportunities? - RTTNews
Kamada Ltd. (KMDA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Tangible book value per share of Kamada Ltd – TASE:KMDA - TradingView
Kamada's (TLV:KMDA) Performance Is Even Better Than Its Earnings Suggest - simplywall.st
How supply chain issues affect Kamada Ltd. stockFed Meeting & Capital Efficient Trading Techniques - newser.com
Why Kamada Ltd. stock is favored by pension funds2025 Market Overview & Weekly Market Pulse Updates - newser.com
Is Kamada Ltd. stock resilient to inflationJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Using Ichimoku Cloud for Kamada Ltd. technicalsEarnings Performance Report & Technical Pattern Alert System - newser.com
How Kamada Ltd. stock compares to growth peersGlobal Markets & High Conviction Trade Alerts - newser.com
Is Kamada Ltd. stock in correction or buying zone2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Why Kamada Ltd. stock is in analyst buy zoneWeekly Market Report & Weekly Top Gainers Alerts - newser.com
Risk adjusted return profile for Kamada Ltd. analyzedJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
How Kamada Ltd. stock performs in stagflationTrade Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Kamada Ltd. Reports Strong Growth Amid Challenges - MSN
Is Kamada Ltd. stock attractive after correction2025 Major Catalysts & Safe Capital Growth Trade Ideas - newser.com
Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year - NewMediaWire
Price action breakdown for Kamada Ltd.2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):